SCHEMBL1246514

SCHEMBL1246514

c1cnc2c(c1)ccc1c2ccc2cccnc21

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.75
CCR8 P51685 5/20 0.75
LMNA P02545 3/20 0.75
CCR5 P51681 3/20 0.75
MMP2 P08253 2/20 0.75
TSHR P16473 2/20 0.75
KDM4E B2RXH2 2/20 0.75
MAPT P10636 2/20 0.75
CYP3A4 P08684 2/20 0.75
HSP90AA1 P07900 2/20 0.75
GMNN O75496 1/20 0.75
TP53 P04637 1/20 0.75
CYP2D6 P10635 1/20 0.75
MMP9 P14780 1/20 0.75
ALOX15 P16050 1/20 0.75
NFKB1 P19838 1/20 0.75
MMP8 P22894 1/20 0.75
THPO P40225 1/20 0.75
MTOR P42345 1/20 0.75
HTT P42858 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30317540 0.89 LMNA (0.62) CCR1CCR8LMNACCR5MMP2
SCHEMBL686683 0.89 LMNA (0.62) CCR1CCR8LMNACCR5MMP2
SCHEMBL22320767 0.89 LMNA (0.62) CCR1CCR8LMNACCR5MMP2
SCHEMBL2061404 0.89 LMNA (0.62) CCR1CCR8LMNACCR5MMP2
Hydrochloric Acid SCHEMBL27597963 0.87 LMNA (0.60) CCR1CCR8LMNACCR5MMP2
Phenanthroline SCHEMBL8845760 0.86 CCR1 (1.00) CCR1CCR8LMNACCR5MMP2
Phenanthroline SCHEMBL29367277 0.86 CCR1 (1.00) CCR1CCR8LMNACCR5MMP2
Phenanthroline SCHEMBL29354015 0.86 CCR1 (1.00) CCR1CCR8LMNACCR5MMP2
Phenanthroline SCHEMBL8312 0.86 CCR1 (1.00) CCR1CCR8LMNACCR5MMP2
SCHEMBL14884168 0.85 CCR1 (0.56) CCR1CCR8LMNACCR5MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035620-B2 Composition and an electronic device containing a sensitizer and a fluorescent emitter UDC IRELAND LIMITED (IE) 2024-07-09 US disclosed
US-12035620-B2 Composition and an electronic device containing a sensitizer and a fluorescent emitter UDC IRELAND LIMITED (IE) 2024-07-09 US disclosed
US-20240208948-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2024-06-27 US disclosed
US-20240215439-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2024-06-27 US disclosed
US-20240215439-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2024-06-27 US disclosed
US-20240074304-A1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING BLUE LIGHT SAMSUNG DISPLAY CO., LTD. (KR) 2024-02-29 US disclosed
US-20240032317-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-25 US disclosed
US-20240032420-A1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING GREEN LIGHT SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-25 US disclosed
US-20240032420-A1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING GREEN LIGHT SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-25 US disclosed
US-20230380199-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-23 US disclosed
US-20120153269-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-06-21 US disclosed
US-20120153269-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-06-21 US disclosed
US-20120153269-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-06-21 US disclosed
WO-2012074111-A1 BINUCLEAR METAL COMPLEX, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME 宇部興産株式会社 (JP) 2012-06-07 WO disclosed
WO-2011024391-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-03-03 WO disclosed
WO-2011024391-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-03-03 WO disclosed
WO-2011021545-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-02-24 WO disclosed
WO-2011021545-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-02-24 WO disclosed
WO-2011021545-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-02-24 WO disclosed
US-20090170890-A1 METHOHDS OF INHIBITING VIRAL INFECTION FUNCTIONAL GENETICS, INC. (US) 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240215439-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES OCIAD2, OR10J3, EPCAM CCR1 1576/4885CCR8 1746/4885LMNA 1482/4885
US-20240208948-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES L1CAM, OCIAD2, EPCAM CCR1 1646/4885CCR8 2337/4885LMNA 834/4885
US-20120153269-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME DDT, OR10J3, SUN2 CCR1 3979/4885CCR8 3284/4885LMNA 3585/4885
US-20090170890-A1 METHOHDS OF INHIBITING VIRAL INFECTION CASP8, CASP1, CASP3 CCR1 911/4885CCR8 121/4885LMNA 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.